Navellier & Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $421K | Hold |
9,100
| – | – | 0.05% | 227 |
|
|
2025
Q1 | $456K | Sell |
9,100
-5,056
| -36% | -$253K | 0.06% | 216 |
|
|
2024
Q4 | $801K | Buy |
14,156
+4,056
| +40% | +$229K | 0.1% | 188 |
|
|
2024
Q3 | $523K | Sell |
10,100
-4,151
| -29% | -$215K | 0.07% | 213 |
|
|
2024
Q2 | $592K | Sell |
14,251
-300
| -2% | -$12.5K | 0.07% | 218 |
|
|
2024
Q1 | $789K | Buy |
+14,551
| New | +$789K | 0.1% | 178 |
|